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1. Introduction
  Malarial pigment haemozoin (HZ) is a ferriprotoporphyrin 
IX crystal produced by Plasmodium parasite after 
host haemoglobin catabolism, present in late stages of 
parasitized red blood cells (trophozoites) and in residual 
bodies shed after schizogony, which is avidly phagocytosed 
by human phagocytic cells[1]. In human monocytes it 
persists undigested for at least 72 hours in the intact 
lysosomes[2]: as a consequence, it impairs a large number 
of their functions, including repeated phagocytosis, antigen 
presentation, oxidative burst, bacterial killing, coordination 
of erythropoiesis[3,4], and stimulates overproduction of 
several cytokines, chemoattractant molecules and stress-
dependent anti-apoptotic molecules[5]. Recently, HZ was 
also shown to enhance the production of two enzymes 
stored in so-called gelatinase granules: lysozyme and 
matrix metalloproteinase-9 (MMP-9)[3, 6-8], a proteolytic 
enzyme related to degradation of basement membranes, 
cleavage of inflammatory molecule proforms and 
disruption of inter-endothelial tight junctions[9,10]. Such 
an enhancement appeared to be directly connected to HZ-
dependent production of tumor necrosis factor (TNF)alpha 
and interleukin (IL)-1beta[3, 6-8]. However, due to the large 
amount of often redundant soluble factors produced after 
phagocytosis[5], it is likely that MMP-9 enhancement may 
not be limited to the action of these two cytokines only. 
Since literature data indicated macrophage inflammatory 
protein (MIP)-1alpha as a positive regulator of MMP-
9[11], in the present study MIP-1alpha protein levels after 
HZ phagocytosis were measured in human monocyte 
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supernatants; therefore, a possible role for this molecule 
in the induction of MMP-9 expression, release and activity 
was investigated by using two combined approaches: a 
mimicking approach with recombinant human MIP-1alpha 
and a blocking approach with anti-human MIP-1alpha 
antibodies. As it will be described in the following sections, 
HZ promoted the production of MIP-1alpha and enhanced 
the expression and release of proMMP-9 protein and active 
enzyme, and MIP-1alpha appeared causally connected to 
MMP-9 enhancement at all levels investigated.
 
2. Materials and methods
2.1. Materials 
  Unless otherwise stated, reagents were obtained from 
Sigma-Aldrich, St. Louis, MO. Sterile plastics were from 
Costar, Cambridge, UK; Panserin 601 monocyte medium 
was from PAN Biotech, Aidenbach, Germany; Percoll was 
from Pharmacia, Uppsala, Sweden; Diff-Quik parasite 
stain was from Baxter Dade AG, Dudingen, Switzerland; 
enzyme-linked immunoadsorbent assay (ELISA) kit, anti-
human MIP-1alpha blocking antibodies and recombinant 
human MIP-1alpha were from R&D Systems, Minneapolis, 
MN; TRIzol, M-MLV, oligo-dT, sense and anti-sense primers 
and Platinum Taq DNA Polymerase were from Invitrogen, 
Carlsbad, CA; DNA-free kit was from Ambion, Austin, TX; 
Beacon Designer 2.1 software was from Premier Biosoft 
International, Palo Alto, CA; dNTPs were from Applied 
Biosystem, Foster City, CA; anti-human MMP-9 monoclonal 
antibodies were from Santa Cruz Biotechnology, Santa Cruz, 
CA; ECL Kit and HRP-conjugated anti-mouse secondary 
antibodies were from GE-Healthcare, Milan, Italy; Geldoc 
computerized densitometer and electrophoresis reagents 
were from Bio-Rad Laboratories, Hercules, CA.
2.2. Culturing of Plasmodium falciparum and isolation of 
HZ.
  Plasmodium falciparum (P. falciparum parasites) (Palo Alto 
strain, mycoplasma-free) were kept in culture as described. 
After centrifugation at 5 000 伊 g on a discontinuous Percoll-
mannitol density gradient, HZ was collected from the 0%-
40% interphase, washed five times with 10 mM HEPES (pH 
8.0) containing 10 mM mannitol at 4 曟 and once with PBS, 
and stored at 20% (v/v) in PBS at -20 曟 or immediately 
used for opsonization and phagocytosis. 
2.3. Preparation and handling of monocytes 
  Human monocytes were separated by Ficoll centrifugation 
from freshly collected buffy coats discarded from blood 
donations by healthy adult donors of both sexes provided 
by the local blood bank (Associazione Volontari Italiani 
Sangue, Torino, Italy)[6]. Separated lympho-monocytes were 
resuspended in RPMI 1640 medium and plated on wells of 
6-well plates. Each well received 2 mL of cell suspension 
containing 8伊106 cells/mL in RPMI 1640. The plates were 
incubated in a humidified CO2/air-incubator at 37 曟 for 
60 min. Thereafter non-adherent cells were removed by 
3 washes with RPMI 1640 and adherent cells reincubated 
at 37 曟 overnight in RPMI 1640. Shortly before starting 
phagocytosis, wells were washed with RPMI 1640 and 
Panserin medium added (2 mL/well). 
2.4. Phagocytosis of opsonized latex particles or HZ and 
treatment with recombinant human MIP-1alpha or anti-
human MIP-1alpha blocking antibodies
  Latex particles and HZ washed once and finely dispersed 
at 30% (v/v) in PBS were added to the same volume of 
fresh human AB serum (AVIS blood bank) and incubated 
for 30 min at 37 曟 to reach opsonization as described[6]. 
Phagocytosis was started by adding to adherent monocytes 
opsonized latex particles or HZ (50 RBC equivalents, in 
terms of heme content, per monocyte). The plates were then 
incubated in Panserin 601 medium in a humidified CO2/
air-incubator at 37 曟 for 2 h. This time period maximized 
phagocytosis and was not sufficient to induce heme-
oxygenase-mediated degradation of ingested heme[2]. As 
an average, each monocyte ingested HZ equivalent approx. 
to 8-10 trophozoites in terms of ingested heme, as shown 
previously. After phagocytosis, cells were washed and 
incubated in Panserin 601 medium in presence/absence of 
anti-human MIP-1alpha blocking antibodies (30 ng/mL) or 
recombinant human MIP-1alpha (20 ng/mL) in a humidified 
CO2/air-incubator at 37 曟  for the indicated times. 
2.5. Measurement of MIP-1alpha production by ELISA
  After termination of phagocytosis, monocytes were further 
incubated with Panserin 601 monocyte medium in a 
humidified CO2/air-incubator at 37 曟 for 24 h. The level of 
secreted MIP-1alpha was assayed in monocyte supernatants 
by specific ELISA, according to the manufacturer’s 
instructions. A standard calibration curve was generated 
with recombinant human MIP-1alpha. 
2.6. Measurement of MMP-9 mRNA levels by real-time RT-
PCR
  After termination of phagocytosis, monocytes were 
further incubated with Panserin 601 monocyte medium 
in a humidified CO2/air-incubator at 37 曟 for 15 h. Total 
cellular RNA from 2伊106 cells was isolated from monocytes 
by TRIzol, according to the manufacturer’s instructions, and 
eluted in 20 毺L diethyl pyrocarbonate water. To remove any 
contaminating DNA, RNA was treated with Ambion’s DNA-
free kit. Subsequently, 6 毺g of RNA were reverse transcribed 
into single-stranded cDNA using M-MLV (200 U/毺L
final concentration) and oligo-dT (25 毺g/毺L final 
concentration). Real Time RT-PCR analysis was performed 
with the iCycler Instrument and the iCycler iQ Real Time 
Detection System Software version 3.0 (Biorad, Hercules, 
CA) as previously described[6]. MMP-9 (GenBank accession 
no. NM_004994) primers (forward: 5’-CCT GGA GAC CTG AGA 
ACC AAT C-3’, reverse: 5’-CTC TGC CAC CCG AGT GTA AC-3’) 
were obtained from Invitrogen. Oligonucleotide sequences 
were identified using Beacon Designer Software package 
(PREMIER Biosoft International, Palo Alto, CA) and designed 
to be intron-spanning allowing the differentiation between 
cDNA and DNA-derived PCR products. As housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
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was used; primer sequences  were from the Bio-Rad library: 
forward: 5’-GAA GGT GAA GGT CGG AGT-3’ and reverse: 5’-
CAT GGG TGG AAT CAT ATT GGA A-3’. For each 25 毺L PCR 
reaction mix: 1 毺L cDNA (corresponding to 10
5 cells); 1.0 毺L
sense primer (10 毺M); 1.0 毺L anti-sense primer (10 毺M);
0.5 毺L dNTP (10 mM); 1.5 毺L MgCl2 (50 mM); 1.25 U 
Platinum Taq DNA Polymerase; 2.5 毺L Buffer (10伊); 1.7 毺L
SYBR Green (stock 1:10 000); and 14.55 毺L PCR-grade 
water were mixed together. DNA polymerase was pre-
activated for 2 min at 94 曟 and the amplification was 
performed by 50 cycles (MMP-9) or 35 cycles (GAPDH) with
denaturation at 94 曟 for 30 s, annealing at 60 曟 for 30 s 
and extension at 72 曟 for 30 s. Relative quantification 
for MMP-9, expressed as -fold variation over untreated 
control cells, was calculated with the efficiency-corrected 
quantification model[12] after determination of the difference 
between CT of the given gene A (MMP-9) and that of the 
calibrator gene B (GAPDH). CT values are means of triplicate 
measurements. To validate the use of the method, serial 
dilutions of cDNA from monocytes, stimulated for 15 h by 
20 ng/mL rhTNFalpha, were tested. Analyzed transcripts 
exhibited high linearity amplification plots (r>0.98) and 
similar PCR efficiency (99.7% for MMP-9 and 92.2% for 
GAPDH), confirming that the expression of each of these 
genes can be directly compared to one another. The 
specificity of PCRs was confirmed by melt curve analysis. 
The melting temperatures for each amplification product 
were 85.8 曟 for MMP-9 and 86.5 曟 for GAPDH.
2.7. Measurement of proMMP-9 protein release levels by 
Western blotting
  After termination of phagocytosis, monocytes were 
further incubated with Panserin 601 monocyte medium 
in a humidified CO2/air-incubator at 37 曟 for 24 h. 
Thereafter cell supernatants were collected and 15 毺L 
cell supernatants/lane were added to the loading buffer. 
The samples were loaded on 8% polyacrylamide gels 
under denaturing and reducing conditions, with addition 
of Laemmli buffer, blotted on a polyvinylidene difluoride 
membrane, and probed with anti-human MMP-9 monoclonal 
antibodies at 1/1 000 final dilution. Bands were visualized by 
enhanced chemiluminescence. Densitometric analysis of the 
bands was performed using a computerized densitometer. 
2.8. Measurement of active MMP-9 protein release levels by 
gelatin zymography 
  After termination of phagocytosis, monocytes were further 
incubated with Panserin 601 monocyte medium in a 
humidified CO2/air-incubator at 37 曟 for 24 h. Thereafter 
the levels of active MMP-9 were evaluated by gelatin 
zymography in the cell supernatants as indicated[13]. 
Briefly, 15 毺L cell supernatants/lane were loaded on 
8% polyacrylamide gels containing 0.1% gelatin under 
non-denaturing and non-reducing conditions. Following 
electrophoresis, gels were washed at room temperature 
for 2 h in milliQ water containing 2.5% (v/v) Triton-X100 
and incubated for 18 h at 37 曟 in a collagenase buffer 
containing (mM): NaCl, 200; Tris, 50; CaCl2, 10; and 0.018% 
(v/v) Brij 35, pH 7.5, with or without 5 mM EDTA to exclude 
aspecific bands. At the end of the incubation, the gels were 
stained for 15 min  with Coomassie blue (0.5% Coomassie 
blue in methanol/acetic acid/water at a ratio of 30:10:60). 
The gels were destained in milliQ water. Densitometric 
analysis of the bands, reflecting total levels of active MMP-9, 
was performed using a computerized densitometer.
2.9. Statistical analysis 
  For each set of experiments, data are showed as Means
依SEM or one representative imagine of three independent 
experiments. All data were analyzed by Student’s t-test 
(equal variances).
 
3. Results
3.1. HZ promotes production of MIP-1alpha by human 
adherent monocytes
  Human adherent monocytes were unfed (control cells), fed 
with latex particles (control meals), or fed with HZ for 2 h. 
After termination of phagocytosis, cells were incubated for 
24 h; therefore, supernatants were collected and MIP-1alpha 
protein levels were measured by specific ELISA. Figure 1 
shows mean values 依 SEM of MIP-1alpha ng/mL produced 
by human monocytes in three independent experiments. 
HZ (column 3) induced a ~20-fold enhancement of basal 
levels (column 1) of MIP-1alpha. Such an increase was not 
dependent on phagocytosis per se, since inert latex particles 
(column 2) did not promote any significant alteration. Data 
were analyzed by Student’s t-test, and following differences 
were obtained. Latex-fed cells versus control cells: no 
significant differences; HZ-fed cells versus control/latex-
fed cells: P<0.05.
3.2. HZ enhances MMP-9 mRNA expression in human 
adherent monocytes: role of MIP-1alpha
  Human adherent monocytes were unfed (control cells), fed 
with latex particles (control meals), or fed with HZ for 2 h.
After termination of phagocytosis, cells were incubated 
in presence/absence of recombinant human MIP-1alpha 
or anti-human MIP-1alpha blocking antibodies for 15 h. 
Therefore, MMP-9 mRNA expression was analyzed by Real-
time RT-PCR in monocyte lysates. As shown in Figure 2, 
MMP-9 mRNA levels in HZ-treated cells (column 2) were 
~60-fold higher than in control cells (column 1). Addition 
of recombinant human MIP-1alpha to unfed cells (column 
3) induced a ~15-fold increase of MMP-9 mRNA levels 
compared to controls, following the HZ trend; the effect of 
HZ was abrogated when anti-human MIP-1alpha blocking 
antibodies were added (column 4), since cells showed 
MMP-9 mRNA levels similar to controls. As expected, 
latex particles did not alter basal levels of MMP-9 mRNA 
(not shown). Data were analyzed by Student’s t-test, and 
following differences were obtained. HZ-fed cells versus 
control cells: P<0.001; unfed cells treated with recombinant 
human MIP-1alpha versus control cells: P<0.05; HZ-fed 
cells treated with anti-human MIP-1alpha antibodies versus 
HZ-fed cells: P<0.001; unfed cells treated with recombinant 
human MIP-1alpha versus HZ-fed cells: P<0.05; HZ-fed 
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cells treated with anti-human MIP-1alpha antibodies versus 
control cells: no significant differences.
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Figure 1. HZ-depentlent enhancement of MIP-1alpha production by 
human adherent monocytes.
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Figure 2. Role of MIP-1alpha in the HZ-dependent enhancement of 
MMP-9 mRNA expression in human adherent monocytes.
3.3. HZ enhances proMMP-9 protein release by human 
adherent monocytes: role of MIP-1alpha 
  Human adherent monocytes were unfed (control cells), fed 
with latex particles (control meals), or fed with HZ for 2 h.
After termination of phagocytosis, cells were incubated 
in presence/absence of anti-human MIP-1alpha blocking 
antibodies or recombinant human MIP-1alpha for 24 h. 
Therefore, proMMP-9 protein release was analyzed by 
Western blotting and optical densitometry in monocyte 
supernatants. Figure 3 shows a representative blot (upper 
panel, 92-kDa positive bands corresponding to proMMP-9) 
and mean values 依 SEM of arbitrary densitometric units from 
three independent experiments (lower panel). ProMMP-9 
protein levels in HZ-treated cells (lane/column 2) were 
~7-fold higher than in control cells (lane/column 1). 
Addition of recombinant human MIP-1alpha to unfed cells 
(lane/column 3) mimicked the HZ trend, showing a ~6-fold 
increase of proMMP-9 protein levels compared to controls. 
The effect of HZ was abrogated when anti-human MIP-
1alpha blocking antibodies were added (lane/column 4), 
cells showing proMMP-9 protein levels similar to controls. 
As expected, latex particles did not alter basal levels of 
proMMP-9 protein (not shown). Data were analyzed by 
Student’s t-test, and following differences were obtained. 
HZ-fed cells versus control cells: P<0.001; unfed cells 
treated with recombinant human MIP-1alpha versus control 
cells: P<0.05; HZ-fed cells treated with anti-human MIP-
1alpha antibodies versus HZ-fed cells: P<0.001; unfed cells 
treated with recombinant human MIP-1alpha versus HZ-
fed cells: P<0.05; HZ-fed cells treated with anti-human 
MIP-1alpha antibodies versus control cells: no significant 
differences.
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Figure 3. Role of MIP-1alpha in the HZ-dependent enhancement of 
proMMP-9 protein release from human adherent monocytes.
3.4. HZ enhances active MMP-9 protein release by human 
adherent monocytes: role of MIP-1alpha 
  Human adherent monocytes were unfed (control cells), fed 
with latex particles (control meals), or fed with HZ for 2 h.
After termination of phagocytosis, cells were incubated 
in presence/absence of anti-human MIP-1alpha blocking 
antibodies or recombinant human MIP-1alpha for 24 h. 
Therefore, active MMP-9 protein release was analyzed by 
gelatin zymography and optical densitometry in monocyte 
supernatants. Figure 4 shows a representative gel (upper 
panel, 83-kDa negative bands corresponding to active 
MMP-9) and mean values 依 SEM of arbitrary densitometric 
units from three independent experiments (lower panel). 
Active MMP-9 levels in HZ-treated cells (lane/column 2) 
were ~7-fold higher than in control cells (lane/column 1). 
Addition of recombinant human MIP-1alpha to unfed cells 
(lane/column 3) mimicked the HZ trend, showing a ~6-fold 
increase of active MMP-9 levels compared to controls. The 
effect of HZ was abrogated when anti-human MIP-1alpha 
blocking antibodies were added (lane/column 4), since 
active MMP-9 levels were similar to controls. As expected, 
latex particles did not alter basal levels of active MMP-9 
protein (not shown). Data were analyzed by Student’s t-test, 
and following differences were obtained. HZ-fed cells versus 
control cells: P<0.001; unfed cells treated with recombinant 
human MIP-1alpha versus control cells: P<0.05; HZ-fed 
cells treated with anti-human MIP-1alpha antibodies versus 
HZ-fed cells: P<0.001; unfed cells treated with recombinant 
human MIP-1alpha versus HZ-fed cells: P<0.05; HZ-fed 
cells treated with anti-human MIP-1alpha antibodies versus 
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control cells: no significant differences. 
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Figure 4. Role of MIP-1alpha in the HZ-dependent enhancement of 
active MMP-9 protein release from human adherent monocytes.
 
4. Discussion
  During the recent years, growing evidence on the 
involvement of MMPs in malaria pathogenesis has been 
shown[3, 14, 15]. These proteolytical enzymes appear 
causally connected to clinical progress towards severe 
malaria complications such as cerebral malaria (CM), an 
encephalopathy associated with cytoadherence of parasitized 
red blood cells (pRBCs) to the endothelium, recruitment 
of immune cells, release of inflammatory and vasoactive 
mediators, blood brain barrier damage, brain oedema, ring-
haemorrhages, and occasionally presence of pRBCs and 
leukocytes in the extravascular space[16, 17]. Enhanced levels 
of MMPs have been described in either human or murine 
malaria models: MMP-9 mRNA was higher in full blood of 
human patients with severe malaria[18], whereas serum MMP-
8[19] and brain MMP-1[20] were enhanced in human patients 
with CM; additionally, mRNA or protein levels of several 
MMPs were found elevated in brains from murine models of 
CM[14, 21]. 
  Interestingly, HZ was shown in vitro to promote MMP-9 
production by several human or murine cell types, 
including adherent or immunopurified monocytes isolated 
from human peripheral blood[6], human THP-1 monocytic 
cell line[22], human microvascular endothelial cells[23], 
human umbilical cord vein endothelial cells[3] and murine 
RAW264.7 macrophage cell line[24]. The ferric moiety of HZ primes 
the activation of proMMP-9 by other MMPs through directly binding 
of its haemopexin domain[25], while the lipid moiety of HZ seems 
to be related to the inflammation-mediated enhancement of 
MMP-9 gene induction and protein release[5, 7,8,23,24].
  The pattern of genes of proinflammatory molecules 
induced after phagocytosis of HZ by human monocytes is 
quite extended, and includes TNFalpha and IL-1beta (whose 
production has been directly related to HZ-dependent 
MMP-9 enhancement)[6-8], as well as several chemokines[5]. 
Interestingly, to this list belongs also MIP-1alpha, which is 
able to induce MMP-9 gene expression[11]. 
  The present study investigated the effects in vitro of HZ on 
MIP-1alpha protein release from human adherent monocytes 
and the potential role of this chemokine in the HZ-
dependent upregulation of MMP-9 gene expression, protein 
release and activity. 
  Results showed that basal levels of MIP-1alpha released 
by monocytes were enhanced by HZ. Such an enhancement 
was not a consequence of phagocytosis per se, since 
inert latex particles did not reproduce HZ effects. This 
evidence is consistent with previous data obtained from 
in vitro[26, 27] and in vivo[28,29] models showing increased 
production of MIP-1alpha by mononuclear cells. Moreover, 
the increased production of MIP-1alpha appeared to be 
causally connected to the HZ-dependent enhancement 
of MMP-9 mRNA expression and of proMMP-9 and active 
MMP-9 protein release. Indeed, anti-human MIP-1alpha 
blocking antibodies abrogated the effects of HZ on MMP-9 
at all levels investigated, whereas unfed cells treated with 
recombinant human MIP-1alpha showed higher levels 
of MMP-9 mRNA expression, protein release and enzyme 
activation, mimicking the trend of HZ phagocytosis effects. 
These results are analogous to those obtained from blocking/
mimicking experiments performed for TNFalpha and IL-
1beta in previous studies[6,7]: thus, they underline the 
redundant role of proinflammatory molecules produced by 
monocytes as a response to HZ stimulus and justify future 
research on the possible use of broad-spectrum instead of 
specific anti-inflammatory drugs as adjuvant therapy for 
complicated malaria.
  Unfortunately, the mechanisms through which HZ exerts 
its stimulatory action on MMP-9 and related inflammatory 
molecules MIP-1alpha, TNFalpha and IL-1beta are not yet 
fully understood. Indeed, the HZ-dependent enhancement of 
MIP-1alpha has been related to the ferric moiety of malarial 
pigment either in human[5] or murine[28] models, whereas 
the increased production of TNFalpha, IL-1beta and MMP-9 
is triggered by the lipid moiety of HZ, and particularly 
by 15- hydroxyeicosatetraenoic acid (15-HETE), a potent 
lipoperoxidation derivative generated by HZ through haem 
autocatalysis[7,8]. Additionally, either human[30] or murine[29] 
models suggest that HZ enhances MIP-1alpha expression 
through MAP kinases pathways (specifically ERK1/2 
phosphorylation), while the HZ-dependent enhancement of 
the triade IL-1beta/TNFalpha/MMP-9 requires the activation 
of NF-毷B pathway[8,22]. However, these data might be not 
conflicting, since the mechanisms of HETE-dependent NF-毷B 
activation have been suggested to involve also MAP kinases 
(ERK1/2, JNK and p38 cascades), which might be required 
for stabilized messenger transcripts[31]. Meanwhile, in the 
murine system, HZ induced MIP-1alpha production through 
ERK1/2- either dependent or independent mechanisms[29], 
suggesting that concomitant activation of some parallel 
pathways which might synergize rather than compete may 
occur. Nevertheless, future studies are certainly required in 
order to clarify the mechanisms underlying cell responses to 
HZ.
  In conclusion, the present work supplies new evidence on 
the inflammation-dependent enhancement of MMP-9 by 
HZ. As a future perspective, the use of anti-inflammatory 
drugs, as well as the use of synthetic MMP inhibitors, 
might be useful to prevent or cure complicated malaria. 
Interestingly, recent studies using anti-inflammatory drugs 
in rodent models of complicated malaria led to promising 
results: high doses of dexamethasone blocked malaria-
associated acute respiratory distress syndrome[32] and beta-
interferon suppressed the development of experimental 
CM[33]. Similarly, the use of BB-94, a broad-spectrum MMP 
inhibitor, significantly increased the survival rate of mice 
with CM[21]. Therefore, a better understanding of dynamics 
of pro-inflammatory response and MMP regulation during 
malaria should be strongly encouraged in a reasonable 
perspective to look for new adjuvant therapies for 
complicated malaria.
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